Insider Trading May 1, 2026 07:10 PM

UL Solutions CEO Executes $1.14 Million Stock Sale via Rule 10b5-1 Plan

Jennifer Scanlon disposes of 12,500 shares amid recent strong financial performance and strategic acquisitions.

By Hana Yamamoto ULS
UL Solutions CEO Executes $1.14 Million Stock Sale via Rule 10b5-1 Plan
ULS

Jennifer F. Scanlon, the President and CEO of UL Solutions Inc. (NASDAQ:ULS), has completed a sale of company stock totaling more than $1.14 million. The transaction, which occurred on May 1, 2026, involved the sale of 12,500 shares of the firm's Class A Common Stock. This divestment was carried out under a Rule 10b5-1 trading plan that had been established by Ms. Scanlon on December 9, 2025.The sale took place as UL Solutions shares were trading in proximity to their 52-week high of $94.03. While the company has seen a significant 58% return over the last year, some analytical data suggests that the current share price may be overvalued relative to its estimated fair value. The company maintains a market capitalization of $18.21 billion and carries a Price/Book ratio of 14.43.

Key Points

  • UL Solutions demonstrated strong financial health in Q4 2025, with an EPS of $0.53 that beat projections by over 29%.
  • The company is aggressively pursuing growth through a $670 million acquisition of Eurofins Scientific SE's Electrical & Electronics business.
  • Insider selling occurred via a pre-established 10b5-1 plan while the stock was trading near its annual highs.

UL Solutions Inc. (NASDAQ:ULS) saw significant insider activity on May 1, 2026, when President and CEO Jennifer F. Scanlon disposed of 12,500 shares of Class A Common Stock. The total value of these transactions reached approximately $1,144,595.

The transaction was executed in two distinct segments with varying price points. The first portion consisted of 9,532 shares sold at a weighted average price of $91.4294. Individual trades within this group fluctuated between $90.84 and $91.83 per share. The second portion involved the sale of 2,968 shares at a weighted average price of $92.0117, with individual trade prices ranging from $91.84 to $92.41 per share. These sales were conducted in accordance with a Rule 10b5-1 trading plan that Ms. Scanlon had adopted on December 9, 2025.

Following the completion of these trades, Ms. Scanlon's direct holdings in UL Solutions Class A Common Stock stand at 188,274 shares. Additionally, she maintains an indirect holding of 89,285 shares through a family trust.


Market Context and Financial Performance

The timing of this insider sale coincides with a period of robust stock performance for UL Solutions. The company's stock has realized a 58% return over the past year and has been trading near its 52-week high of $94.03. Despite this momentum, some assessments indicate that the shares are currently trading above their fair value estimate. The organization holds an $18.21 billion market capitalization and operates with a Price/Book ratio of 14.43.

Recent financial data for UL Solutions highlights strong operational results. In the fourth quarter of 2025, the company reported earnings per share (EPS) of $0.53, which exceeded market expectations by 29.27% compared to the projected $0.41. Quarterly revenue also showed growth, reaching $789 million, a 6.8% increase year-over-year.

Strategically, UL Solutions has been expanding its footprint through acquisitions and innovation. The company entered into a definitive agreement to purchase the Electrical & Electronics business from Eurofins Scientific SE for an estimated $670 million. This move is intended to bolster global laboratory capabilities and is projected to contribute $200 million in revenue by 2026. Furthermore, the company recently issued its first safety certification for Simbe’s Tally, a robot designed for use in public environments.


Key Investment Drivers

  • Strong Earnings Momentum: The company's recent Q4 2025 results showed a significant earnings surprise and steady revenue growth of 6.8%.
  • Strategic Expansion: The $670 million acquisition of Eurofins Scientific SE's Electrical & Electronics unit aims to increase global laboratory capacity and revenue by 2026.
  • Sector Innovation: By granting safety certifications for new technologies like Simbe’s Tally robot, the company is positioning itself within emerging automation and safety markets.

Risk Factors and Market Uncertainties

  • Valuation Concerns: Despite strong returns, there are indications that the stock may be overvalued relative to its fair value estimates.
  • Analyst Divergence: Market sentiment remains split; while BofA Securities has a Buy rating with a $98 price target, UBS maintains a Neutral rating with a $90 target.
  • Integration Risks: The company's growth relies on the successful integration of large-scale acquisitions such as the Eurofins Scientific SE business unit.

Risks

  • Valuation risk exists as current share prices may exceed fair value estimates despite recent 58% gains.
  • Analyst uncertainty is evident in the differing price targets and ratings between major institutions like BofA Securities and UBS.
  • Execution risk regarding the projected $200 million revenue contribution from the upcoming Eurofins acquisition.

More from Insider Trading

Marcus & Millichap Director Executes Substantial Common Stock Purchase May 4, 2026 Patterson-UTI CEO Executes Multi-Million Dollar Stock Sale Amidst Year-to-Date Surge May 4, 2026 Snowflake Director Michael Speiser Executes $7.18 Million in Stock Sales May 4, 2026 Edwards Lifesciences Executive Executes Stock Transactions Amid Recent Financial Growth May 4, 2026 Entrada Therapeutics President and COO Executes Stock Sale via Rule 10b5-1 Plan May 4, 2026